Neuromuscular Study Group Studies
Completed
- Ascorbic Acid Treatment of Charco-Marie Tooth Type 1A (CMT)Year Trial Ends : 2017
- Dichlorphenamide vs. Placebo for the Treatment of Patients with Hyperkalemic or Hypokalemic Periodic Paralysis (HYP-HOP)Year Trial Ends : 2018
- Efficacy of Prednisone in the Treatment of Ocular Myasthenia (EPITOME)Year Trial Ends : 2018
- Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis (MG-SCIg)Year Trial Ends : 2017
- Methotrexate in Myasthenia Gravis (Methotrexate)Year Trial Ends : 2019
- Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis (Rasagiline)Year Trial Ends : 2021
Ongoing (No Longer Recruiting Patients)
- Investigating Pompe Prevalence in Neuromuscular Medicine Academic Practices (IPANEMA)Year Trial Ends : 2018
- Natural History Study of Spinal Muscular Atrophy (SMA)Year Trial Ends : 2020
- Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find the Optimum Steroid Regimen (FOR-DMD)Year Trial Ends : 2024
Recruiting
- The International IBM Consortium Genetic StudyYear Trial Ends : 2027
Not Yet Recruiting
- Arimoclomol in Sporadic Inclusion Body Myositis (Arimoclomol)Year Trial Ends : 2017
Related Studies
- Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
- Mexiletine and Non Dystrophic Myotonias (MYOMEX)
- Characteristics of Episodic Ataxia Syndrome
- Effect of Potassium and Acetazolamide on People With Andersen-Tawil Syndrome
- Characteristics of Andersen-Tawil Syndrome
- Consortium for Clinical Investigation of Neurologic Channelopathies (CINCH)